Bristol-Myers Squibb CompanyBMYNYSE
Loading
SG&A Expenses Over TimeStable
Percentile Rank64
3Y CAGR-2.5%
5Y CAGR-1.1%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-2.5%/yr
vs +14.5%/yr prior
5Y CAGR
-1.1%/yr
Consistent
Acceleration
-16.9pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $7.24B | -7.9% |
| 2024 | $7.87B | +2.4% |
| 2023 | $7.68B | -1.7% |
| 2022 | $7.81B | +1.6% |
| 2021 | $7.69B | +0.5% |
| 2020 | $7.65B | +57.4% |
| 2019 | $4.86B | +6.9% |
| 2018 | $4.55B | -4.2% |
| 2017 | $4.75B | -3.3% |
| 2016 | $4.91B | - |